FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.46), $0.02 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $4.97 million.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
... More
